The authors discuss the differences in mechanism of activation of N-nitrosamides versus N-nitrosamines and the fact that they should not be treated the same.
Chuck Lambert
Advertisement
Chuck Lambert, PhD, DABT, ERT is principal toxicologist at Intrinsik Ltd.
Articles by Chuck Lambert
Advertisement
Latest Updated Articles
Nitrosamides–Should They Be Treated the Same as Nitrosamines?October 15th 2022
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
2
Why Impurity Deficiencies Keep Repeating: AAPS PharmSci 360 2026
3
Why Drug Shortages Average 5+ Years: PharmTech Explained
4
Meeting Tomorrow's Market Requirements: Vetter's Perspective on the Future of Fill & Finish
5